ABVC Biopharma Inc (ABVC) is down Thursday morning, with the stock falling -2.73% in pre-market trading to 1.07. ABVC's short-term technical score of 51 indicates that the stock has traded more bullishly over the last month than 51% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, ABVC Biopharma Inc ranks higher than 68% of stocks. ABVC Biopharma Inc has risen 19.57% over the past month, closing at $0.90 on October 5. During this period of time, the stock fell as low as $0.81 and as high as $3.35. ABVC has an average analyst recommendation of Sell. The company has an average price target of $20.20.
ABVC has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on ABVC!